Performance of High-Dose Omalizumab in Chronic Urticaria is Predicted by Initial Improvement to Standard Dose.
The Journal of Allergy and Clinical Immunology In Practice(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
The Journal of Allergy and Clinical Immunology In Practice(2024)